SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Mak, J. Zhou, L. C. S. Tan, W. L. Au, Y. Y. Sitoh, N. Kandiah, Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 5, 576

    CrossRef

  2. 2
    John N. Caviness, Pathophysiology of Parkinson's disease behavior – a view from the network, Parkinsonism & Related Disorders, 2014, 20, S39

    CrossRef

  3. 3
    Amanda-Amrita D. Lakraj, Bahman Jabbari, Duarte G. Machado, Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics, 2014,

    CrossRef

  4. 4
    Banu Ozen Barut, Dilek Ince Gunal, Çiğdem Turkmen, Aynur Mollahasanoğlu, Handan Ankaralı, Clinical and cognitive profiles of patients with both Parkinson’s disease and essential tremor, Acta Neurologica Belgica, 2013, 113, 2, 117

    CrossRef

  5. 5
    Chaorui Huang, Lisa D. Ravdin, Melissa J. Nirenberg, Panida Piboolnurak, Lawrence Severt, James S. Maniscalco, Lilja Solnes, Benjamin J. Dorfman, Claire Henchcliffe, Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study, Dementia and Geriatric Cognitive Disorders, 2013, 35, 3-4, 183

    CrossRef

  6. 6
    Kathleen L. Poston, David Eidelberg, Functional brain networks and abnormal connectivity in the movement disorders, NeuroImage, 2012, 62, 4, 2261

    CrossRef

  7. 7
    Sharon Ash, Corey McMillan, Rachel G. Gross, Philip Cook, Delani Gunawardena, Brianna Morgan, Ashley Boller, Andrew Siderowf, Murray Grossman, Impairments of speech fluency in Lewy body spectrum disorder, Brain and Language, 2012, 120, 3, 290

    CrossRef

  8. 8
    Francesca Di Biasio, Nicola Vanacore, Alfonso Fasano, Nicola Modugno, Barbara Gandolfi, Francesco Lena, Giovanni Grillea, Sara Pietracupa, Giovanni Caranci, Stefano Ruggieri, Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson’s disease-dementia: which matters most?, Journal of Neural Transmission, 2012, 119, 5, 597

    CrossRef

  9. 9
    Yoland Smith, Thomas Wichmann, Stewart A Factor, Mahlon R DeLong, Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa, Neuropsychopharmacology, 2012, 37, 1, 213

    CrossRef

  10. 10
    Samrat Roychowdhury, Duncan R. Forsyth, Sleep disturbance in Parkinson disease, Journal of Clinical Gerontology and Geriatrics, 2012, 3, 2, 53

    CrossRef

  11. 11
    Dario Arnaldi, Claudio Campus, Michela Ferrara, Francesco Famà, Agnese Picco, Fabrizio De Carli, Jennifer Accardo, Andrea Brugnolo, Gianmario Sambuceti, Silvia Morbelli, Flavio Nobili, What predicts cognitive decline in de novo Parkinson's disease?, Neurobiology of Aging, 2012, 33, 6, 1127.e11

    CrossRef

  12. 12
    Liana G. Apostolova, Steven T. DeKosky, Jeffrey L. Cummings, Neurology in Clinical Practice, 2012,

    CrossRef

  13. 13
    Anne Barba, B Changizi, Donald Higgins, Stewart Factor, Eric Molho, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  14. 14
    Naroa Ibarretxe-Bilbao, Carme Junque, Maria J. Marti, Eduardo Tolosa, Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease, Journal of the Neurological Sciences, 2011, 310, 1-2, 70

    CrossRef

  15. 15
    Paulo Bugalho, Teresa Paiva, Dream features in the early stages of Parkinson’s Disease, Journal of Neural Transmission, 2011, 118, 11, 1613

    CrossRef

  16. 16
    Erin R. Foster, Tamara Hershey, Everyday Executive Function Is Associated with Activity Participation in Parkinson Disease Without Dementia, OTJR: Occupation, Participation, Health, 2011, 31, 1, S16

    CrossRef

  17. You have free access to this content17
    K. E. Cruise, R. S. Bucks, A. M. Loftus, R. U. Newton, R. Pegoraro, M. G. Thomas, Exercise and Parkinson’s: benefits for cognition and quality of life, Acta Neurologica Scandinavica, 2011, 123, 1
  18. 18
    John N. Caviness, LihFen Lue, Charles H. Adler, Douglas G. Walker, Parkinson's Disease Dementia and Potential Therapeutic Strategies, CNS Neuroscience & Therapeutics, 2011, 17, 1
  19. 19
    Ericka C. Holmstrand, Susan R. Sesack, Projections from the rat pedunculopontine and laterodorsal tegmental nuclei to the anterior thalamus and ventral tegmental area arise from largely separate populations of neurons, Brain Structure and Function, 2011, 216, 4, 331

    CrossRef

  20. 20
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  21. 21
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  22. 22
    Erin R. Foster, Meghan C. Campbell, Michelle A. Burack, Johanna Hartlein, Hubert P. Flores, Nigel J. Cairns, Tamara Hershey, Joel S. Perlmutter, Amyloid imaging of Lewy body-associated disorders, Movement Disorders, 2010, 25, 15
  23. You have free access to this content23
    Flavio Nobili, Claudio Campus, Dario Arnaldi, Fabrizio De Carli, Gaia Cabassi, Andrea Brugnolo, Barbara Dessi, Silvia Morbelli, Gianmario Sambuceti, Giovanni Abbruzzese, Guido Rodriguez, Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: A [I-123]FP-CIT SPECT study, Movement Disorders, 2010, 25, 1
  24. 24
    Ezequiel Gleichgerrcht, Agustín Ibáñez, María Roca, Teresa Torralva, Facundo Manes, Decision-making cognition in neurodegenerative diseases, Nature Reviews Neurology, 2010, 6, 11, 611

    CrossRef

  25. 25
    Francesca Antonelli, Nicola Ray, Antonio P Strafella, Imaging cognitive and behavioral symptoms in Parkinson’s disease, Expert Review of Neurotherapeutics, 2010, 10, 12, 1827

    CrossRef

  26. 26
    Ann B. Sollinger, Felicia C. Goldstein, James J. Lah, Allan I. Levey, Stewart A. Factor, Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics, Parkinsonism & Related Disorders, 2010, 16, 3, 177

    CrossRef

  27. 27
    Birgit Högl, Isabelle Arnulf, Cynthia Comella, Joaquim Ferreira, Alex Iranzo, Barbara Tilley, Claudia Trenkwalder, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 16
  28. 28
    Chris C. Tang, David Eidelberg, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  29. 29
    Flavio Nobili, Giovanni Abbruzzese, Silvia Morbelli, Roberta Marchese, Nicola Girtler, Barbara Dessi, Andrea Brugnolo, Cinzia Canepa, Giorgos Chr. Drosos, Gianmario Sambuceti, Guido Rodriguez, Amnestic mild cognitive impairment in Parkinson's disease: A brain perfusion SPECT study, Movement Disorders, 2009, 24, 3
  30. 30
    Turi O. Dalaker, Jan P. Larsen, Niels Bergsland, Mona K. Beyer, Guido Alves, Michael G. Dwyer, Ole-Bjorn Tysnes, Ralph H.B. Benedict, Arpad Kelemen, Kolbjorn Bronnick, Robert Zivadinov, Brain atrophy and white matter hyperintensities in early Parkinson's disease, Movement Disorders, 2009, 24, 15
  31. 31
    Jian Hai, Jue-Feng Wan, Qi Lin, Fei Wang, Lin Zhang, Hui Li, Lan Zhang, Yu-Ying Chen, Yang Lu, Cognitive dysfunction induced by chronic cerebral hypoperfusion in a rat model associated with arteriovenous malformations, Brain Research, 2009, 1301, 80

    CrossRef

  32. You have free access to this content32
    Sarah Jesse, Petra Steinacker, Stefan Lehnert, Frank Gillardon, Bastian Hengerer, Markus Otto, Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review, CNS Neuroscience & Therapeutics, 2009, 15, 2
  33. 33
    K Ray Chaudhuri, Anthony HV Schapira, Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment, The Lancet Neurology, 2009, 8, 5, 464

    CrossRef

  34. 34
    Leslie S. Libow, Pasquale G. Frisina, Vahram Haroutunian, Daniel P. Perl, Dushyant P. Purohit, Parkinson's disease dementia – A diminished role for the Lewy body, Parkinsonism & Related Disorders, 2009, 15, 8, 572

    CrossRef

  35. 35
    Monika Nojszewska, Beata Pilczuk, Beata Zakrzewska-Pniewska, Katarzyna Rowińska-Marcińska, The Auditory System Involvement in Parkinson Disease: Electrophysiological and Neuropsychological Correlations, Journal of Clinical Neurophysiology, 2009, 26, 6, 430

    CrossRef

  36. 36
    Michail E. Kalaitzakis, Ronald K. B. Pearce, The morbid anatomy of dementia in Parkinson’s disease, Acta Neuropathologica, 2009, 118, 5, 587

    CrossRef

  37. 37
    Rufus O. Akinyemi, Njideka N. Okubadejo, Joshua O. Akinyemi, Mayowa O. Owolabi, Lukman F. Owolabi, Adesola Ogunniyi, Cognitive dysfunction in Nigerians with Parkinson's disease, Movement Disorders, 2008, 23, 10
  38. 38
    O. Riedel, J. Klotsche, A. Spottke, G. Deuschl, H. Förstl, F. Henn, I. Heuser, W. Oertel, H. Reichmann, P. Riederer, C. Trenkwalder, R. Dodel, H.-U. Wittchen, Cognitive impairment in 873 patients with idiopathic Parkinson's disease, Journal of Neurology, 2008, 255, 2, 255

    CrossRef

  39. 39
    E. Lyros, L. Messinis, P. Papathanasopoulos, Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia?, European Journal of Neurology, 2008, 15, 3
  40. 40
    BERTA PASCUAL-SEDANO, JAIME KULISEVSKY, MANEL BARBANOJ, CARMEN GARCÍA-SÁNCHEZ, ANTONIA CAMPOLONGO, ALEXANDRE GIRONELL, JAVIER PAGONABARRAGA, IGNASI GICH, Levodopa and executive performance in Parkinson's disease: A randomized study, Journal of the International Neuropsychological Society, 2008, 14, 05

    CrossRef

  41. 41
    Daniel D. Truong, Roongroj Bhidayasiri, Erik Wolters, Management of non-motor symptoms in advanced Parkinson disease, Journal of the Neurological Sciences, 2008, 266, 1-2, 216

    CrossRef

  42. 42
    Chelsea Stamper, Andrew Siegel, Winnie S. Liang, John V. Pearson, Dietrich A. Stephan, Holly Shill, Don Connor, John N. Caviness, Marwan Sabbagh, Thomas G. Beach, Charles H. Adler, Travis Dunckley, Neuronal gene expression correlates of Parkinson's disease with dementia, Movement Disorders, 2008, 23, 11
  43. 43
    Paul S. Foster, Valeria Drago, David B. FitzGerald, Barry M. Skoblar, Gregory P. Crucian, Kenneth M. Heilman, Spreading activation of lexical–semantic networks in Parkinson's disease, Neuropsychologia, 2008, 46, 7, 1908

    CrossRef

  44. You have free access to this content44
    Mariese A. Hely, Wayne G.J. Reid, Michael A. Adena, Glenda M. Halliday, John G.L. Morris, The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years, Movement Disorders, 2008, 23, 6
  45. 45
    Alireza Kashani, Catalina Betancur, Bruno Giros, Etienne Hirsch, Salah El Mestikawy, Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease, Neurobiology of Aging, 2007, 28, 4, 568

    CrossRef

  46. 46
    J.N. Caviness, J.G. Hentz, V.G. Evidente, E. Driver-Dunckley, J. Samanta, P. Mahant, D.J. Connor, M.N. Sabbagh, H.A. Shill, C.H. Adler, Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, 6, 348

    CrossRef

  47. 47
    Nuria Caballol, Maria J Martí, Eduardo Tolosa, Cognitive dysfunction and dementia in Parkinson disease, Movement Disorders, 2007, 22, S17
  48. 48
    Chaorui Huang, Paul Mattis, Chengke Tang, Kenneth Perrine, Maren Carbon, David Eidelberg, Metabolic brain networks associated with cognitive function in Parkinson's disease, NeuroImage, 2007, 34, 2, 714

    CrossRef

  49. 49
    John Stirling Meyer, Juebin Huang, Munir H. Chowdhury, MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias, Journal of the Neurological Sciences, 2007, 257, 1-2, 97

    CrossRef

  50. 50
    A. Wallin, S. Ekberg, K. Lind, V. Milos, A.-K. Granérus, G. Granerus, Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson’s disease – a rCBF scintigraphy study, Acta Neurologica Scandinavica, 2007, 116, 6
  51. 51
    Rita Moretti, Paola Torre, Cristina Vilotti, Rodolfo M. Antonello, Gilberto Pizzolato, Rivastigmine and Parkinson dementia complex, Expert Opinion on Pharmacotherapy, 2007, 8, 6, 817

    CrossRef

  52. 52
    M. Emre, Treatment of dementia associated with Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, S457

    CrossRef

  53. 53
    Murat Emre, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  54. 54
    Dennis J. Zgaljardic, Joan C. Borod, Nancy S. Foldi, Paul J. Mattis, Mark F. Gordon, Andrew Feigin, David Eidelberg, An Examination of Executive Dysfunction Associated with Frontostriatal Circuitry in Parkinson's Disease, Journal of Clinical and Experimental Neuropsychology, 2006, 28, 7, 1127

    CrossRef

  55. 55
    Guido Alves, Jan Petter Larsen, Murat Emre, Tore Wentzel-Larsen, Dag Aarsland, Changes in motor subtype and risk for incident dementia in Parkinson's disease, Movement Disorders, 2006, 21, 8
  56. 56
    Nancy R. Barbas, Cognitive, Affective, and Psychiatric Features of Parkinson's Disease, Clinics in Geriatric Medicine, 2006, 22, 4, 773

    CrossRef

  57. 57
    Craig J. Whittington, John Podd, Steve Stewart-Williams, Memory Deficits in Parkinson’s Disease, Journal of Clinical and Experimental Neuropsychology, 2006, 28, 5, 738

    CrossRef

  58. 58
    Miros??awa Derejko, Jaros??aw S??awek, Dariusz Wieczorek, Bogna Brockhuis, Miros??awa Dubaniewicz, Piotr Lass, Regional cerebral blood flow in Parkinson??s disease as an indicator of cognitive impairment, Nuclear Medicine Communications, 2006, 27, 12, 945

    CrossRef

  59. 59
    M. W. Riepe, J. Kassubek, F. Tracik, G. Ebersbach, Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?, Journal of Neural Transmission, 2006, 113, 10, 1463

    CrossRef

  60. 60
    Mona K. Beyer, Dag Aarsland, Ole Jacob Greve, Jan P. Larsen, Visual rating of white matter hyperintensities in Parkinson's disease, Movement Disorders, 2006, 21, 2
  61. 61
    Basil Ridha, Keith A. Josephs, Young-Onset Dementia, The Neurologist, 2006, 12, 1, 2

    CrossRef

  62. 62
    Hasmet A. Hanagasi, Murat Emre, Treatment of behavioural symptoms and dementia in Parkinson's disease, Fundamental & Clinical Pharmacology, 2005, 19, 2
  63. 63
    Susan Bassett, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  64. 64
    Geoffrey Lane, Lee Hyer, Gerald Leventhal, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  65. 65
    Linda R. White, Mari Gårseth, Jan Aasly, Ursula Sonnewald, Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor, Journal of Neuroscience Research, 2004, 78, 2
  66. 66
    Lawrence Elmer, Cognitive issues in Parkinson's disease, Neurologic Clinics, 2004, 22, 3, S91

    CrossRef

  67. 67
    Barbara Collins, John Constant, Samer Kaba, C Lynn Barclay, Erich Mohr, Dementia with Lewy Bodies, Clinical Neuropharmacology, 2004, 27, 6, 281

    CrossRef

  68. 68
    Andrew H Evans, Andrew J Lees, Dopamine dysregulation syndrome in Parkinson??s disease, Current Opinion in Neurology, 2004, 17, 4, 393

    CrossRef

  69. 69
    Murat Emre, Treatment of Dementia Associated with Parkinson's Disease,